AGOSTINIS, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 8.952
EU - Europa 6.473
AS - Asia 4.734
SA - Sud America 579
AF - Africa 181
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 20.956
Nazione #
US - Stati Uniti d'America 8.778
SG - Singapore 1.762
PL - Polonia 1.454
IT - Italia 1.137
CN - Cina 978
DE - Germania 952
SE - Svezia 567
VN - Vietnam 532
RU - Federazione Russa 504
BR - Brasile 433
HK - Hong Kong 433
GB - Regno Unito 392
UA - Ucraina 322
FR - Francia 294
KR - Corea 262
FI - Finlandia 195
NL - Olanda 165
IN - India 144
TR - Turchia 131
IE - Irlanda 123
BG - Bulgaria 95
CA - Canada 88
JP - Giappone 73
MA - Marocco 60
TW - Taiwan 59
MX - Messico 50
AR - Argentina 48
BE - Belgio 42
ID - Indonesia 42
BD - Bangladesh 39
ZA - Sudafrica 38
AT - Austria 35
IQ - Iraq 35
ES - Italia 28
PK - Pakistan 26
IR - Iran 25
PH - Filippine 25
CH - Svizzera 22
CL - Cile 22
AU - Australia 21
EG - Egitto 20
SA - Arabia Saudita 20
SN - Senegal 20
AE - Emirati Arabi Uniti 19
EC - Ecuador 19
UZ - Uzbekistan 19
CZ - Repubblica Ceca 18
VE - Venezuela 17
HU - Ungheria 16
MY - Malesia 15
PT - Portogallo 15
RO - Romania 15
TH - Thailandia 15
AZ - Azerbaigian 13
IL - Israele 13
CO - Colombia 12
LT - Lituania 12
PE - Perù 12
PY - Paraguay 10
DK - Danimarca 9
TT - Trinidad e Tobago 9
DZ - Algeria 8
MD - Moldavia 8
OM - Oman 8
PA - Panama 8
SI - Slovenia 8
TN - Tunisia 8
EU - Europa 7
GR - Grecia 7
EE - Estonia 6
JO - Giordania 6
KE - Kenya 6
KZ - Kazakistan 6
NO - Norvegia 6
CR - Costa Rica 5
HR - Croazia 5
KG - Kirghizistan 5
LV - Lettonia 5
NP - Nepal 5
RS - Serbia 5
CI - Costa d'Avorio 4
ET - Etiopia 4
GE - Georgia 4
JM - Giamaica 4
LB - Libano 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BW - Botswana 2
BY - Bielorussia 2
CY - Cipro 2
Totale 20.930
Città #
Warsaw 1.351
Singapore 1.070
Ashburn 996
Fairfield 847
Woodbridge 588
Ann Arbor 560
Chandler 554
San Jose 465
Houston 423
Hong Kong 397
Trieste 389
Seattle 369
Wilmington 362
Dallas 349
Cambridge 267
Seoul 253
Jacksonville 243
Beijing 233
Hefei 170
Boardman 163
Ho Chi Minh City 156
Princeton 144
Los Angeles 137
The Dalles 122
Chicago 115
Hanoi 114
Columbus 102
Dublin 101
Moscow 100
Sofia 93
Helsinki 83
New York 83
Santa Clara 83
Lauterbourg 82
London 81
Frankfurt am Main 80
Izmir 80
Zgierz 74
Munich 64
Council Bluffs 59
Buffalo 58
Dearborn 56
Taipei 54
São Paulo 50
Casablanca 46
Shanghai 46
Falls Church 43
Milan 41
Tokyo 40
Düsseldorf 39
North Bergen 38
San Diego 35
Dong Ket 34
Brussels 33
Menlo Park 31
Turku 29
Amsterdam 28
Guangzhou 28
Atlanta 27
Da Nang 26
Saint Petersburg 26
Stockholm 26
Orem 25
Redmond 25
Toronto 25
Des Moines 24
Nanjing 24
Redwood City 24
Fort Wayne 23
Nuremberg 23
Venice 22
Montreal 21
Redondo Beach 21
Dakar 20
Jakarta 20
Treviso 20
Vienna 20
Chennai 19
Jinan 18
Johannesburg 18
Kyiv 18
Lappeenranta 18
Phoenix 18
Rome 18
Washington 18
Arzene 17
Baghdad 17
Bern 17
Brooklyn 17
Denver 16
Duino-Aurisina 16
San Francisco 16
Boston 15
Haiphong 15
Poplar 15
Tashkent 15
Udine 15
Belo Horizonte 14
Buon Ma Thuot 14
Mexico City 14
Totale 13.551
Nome #
The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 856
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 504
RelB activation in anti-inflammatory decidual endothelial cells: a master plan to avoid pregnancy failure? 483
Pharmacokinetics and immunomodulatory effect of lipophilic Echinacea extract formulated in softgel capsules 448
The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis 409
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 395
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 350
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 336
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 332
Pathological significance and prognostic value of surfactant protein D in cancer 305
Pre-eclampsia affects procalcitonin production in placental tissue 302
BIOINFORMATICS ANALYSIS OF THE CLINICOPATHOLOGICAL SIGNIFICANCE AND THE PROGNOSTIC ROLE OF SURFACTANT PROTEIN D IN LUNG, GASTRIC, BREAST AND OVARIAN CANCERS 302
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 301
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells 299
Analysis of anti-C1q antibodies in normal and pathological pregnancies 299
C1q is involved in human trophoblast invasion 297
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 287
C1q is responsible of the anti-inflammatory behavior of decidual endothelial cells 286
Pre-eclampsia is associated with defective production of C1q by invasive trophoblast 283
C1q is associated with a reduced inflammatory response of decidual endothelial cells 281
Soluble TRAIL is elevated in recurrent miscarriage and inhibits the in vitro adhesion and migration of HTR8 trophoblastic cells 273
Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics analysis involving human carcinomas 269
null 263
The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro. 257
Analysis of the cAMP-PCT-CGRP axis in normal and pathological pregnancy 250
Alternative functions of the complement protein C1q at embryo implantation site 248
Combined extracts of Echinacea angustifolia DC. and Zingiber officinale Roscoe in softgel capsules: Pharmacokinetics and immunomodulatory effects assessed by gene expression profiling 248
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 248
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 245
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 242
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 238
The role of complement component C1q in angiogenesis 220
COMPLEMENT PROTEIN C1Q PRODUCTION IN MALIGNANT PLEURAL MESOTHELIOMA 217
Vitreous Prostaglandin E2 Changes after Topical Administration of Diclofenac 0.1%, Indomethacin 0.5%, Nepafenac 0.3%, and Bromfenac 0.09. 214
A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia 213
The seventh complement component is expressed on endothelial cells membrane and exerts an anti-inflammatory action 208
Preeclampsia is associated with defective production of C1q by invasive trophoblast 200
In vivo distribution of {beta}2 glycoprotein I under various pathophysiological conditions 198
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 195
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 191
MBL interferes with endovascular trophoblast invasion in pre-eclampsia. 191
THE CLINICOPATHOLOGICAL AND PROGNOSTIC SIGNIFICANCES OF C1Q EXPRESSION IN GLIOMAS: A BIOINFORMATICS ANALYSIS 190
Overview of procalcitonin in pregnancy and in pre-eclampsia 189
Human recombinant lysozyme downregulates advanced glycan endproduct-induced interleukin-6 production and release in an in vitro model of human proximal tubular epithelial cells 188
Bacterial LPS differently modulates inflammasome gene expression and IL-1β secretion in trophoblast cells, decidual stromal cells, and decidual endothelial cells 188
The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine 188
Emerging Roles of the Complement System at Foeto-maternal Interface 186
A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients 184
The complement system at the embryo implantation site 183
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 175
184 Complement score: A novel prognostic tool in malignant pleural mesothelioma? 172
C1-inhibitor is a novel prognostic factor in malignant pleural mesothelioma and in serous ovarian carcinoma 170
Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating 169
Differential capability of clinically employed dermal regeneration scaffolds to support vascularization for tissue bioengineering 169
Prognostic Implications of the Complement Protein C1q in Gliomas 166
C1q as pro-angiogenic factor in the context of ovarian tissue transplantation 165
The use of quantitative real time polymerase chain reaction to quantify some rumen bacterial strains in an in vitro rumen system 164
The expression of complement component C3 is specifically localized in endometrial ectopic tissue and is involved in the endometriotic lesion formation 162
The anti-pseudomonal peptide d-bmap18 is active in cystic fibrosis sputum and displays anti-inflammatory in vitro activity 162
Ischemic wound revascularization by the stromal vascular fraction relies on host-donor hybrid vessels 161
null 161
null 159
Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I 157
The C7 component of the complement system localizes to vascular smooth muscle cells and endothelium in human first trimester decidua 156
A non-redundant role of complement protein C1q in normal and adverse pregnancy 155
null 155
Proangiogenic properties of complement protein C1q can contribute to endometriosis 154
Complement component C1q can predict patients’ response to cisplatin depending on tumour type: A step towards personalized medicine? 154
null 154
At Embryo Implantation Site IL-35 Secreted by Trophoblast, Polarizing T Cells towards IL-35+ IL-10+ IL-4+ Th2-Type Cells, Could Favour Fetal Allograft Tolerance and Pregnancy Success 154
null 151
COVID-19, Pre-Eclampsia, and Complement System 151
Study of the prognostic significance of the protein C1q in carcinomas 147
Pathophysiology of the Complement System at Feto-Maternal Interface 142
Protection against inflammation- and antiphospholipid antibody-caused fetal loss by the chemokine decoy receptor D6 140
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment 137
null 136
Endothelial cell supplementation promotes xenograft revascularization during short-term ovarian tissue transplantation 135
Zinc Oxide Exerts Anti-Inflammatory Properties on Human Placental Cells 133
Protective and regenerative effects of a novel medical device against esophageal mucosal damage using in vitro and ex vivo models 133
A possible association between low MBL/lectin pathway functionality and microbiota dysbiosis in endometriosis patients 133
Uterine immunity and microbiota: A shifting paradigm 132
The complement protein C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 130
Complement production by trophoblast cells at the feto-maternal interface. 124
null 121
P-424 Placental extracellular matrix remodelling in pregnancies by oocyte donation shows similarities with preeclamptic placenta: a pilot study 119
Genetic bases of C7 deficiency: systematic review and report of a novel deletion determining functional hemizygosity 118
Evaluation of Sars-CoV-2 entry receptors in COVID-19 positive and negative placentae: correlation between expression and infectivity 118
DISTRIBUTION AND FUNCTION OF THE COMPLEMENT PROTEIN C1Q IN MALIGNANT PLEURAL MESOTHELIOMA MICROENVIRONMENT 118
Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target 116
Protective role of complement factor H against the development of preeclampsia 112
null 110
Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium. 109
Prognostic Value of Complement Properdin in Cancer 109
Epigenetic regulation of complement C1Q gene expression 105
Evaluation of levels, specificity and pathophysiology of anti-C1q autoantibodies in pregnancy 104
Anti-miRNA therapeutics for uterine fibroids 104
null 101
null 89
Immunomodulation mediated by a herbal syrup containing astandardized Echinacea root extract: A pilot study in healthy humansubjects on cytokine gene expression 89
Totale 20.739
Categoria #
all - tutte 54.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021362 0 0 0 0 0 0 0 0 0 174 71 117
2021/20221.380 66 57 90 84 55 126 83 73 190 134 85 337
2022/20231.772 168 247 139 268 153 277 28 154 193 24 77 44
2023/20241.334 94 66 110 90 105 150 233 187 52 68 100 79
2024/20252.771 65 94 180 201 260 264 186 156 396 367 282 320
2025/20266.444 810 445 540 673 609 600 1.054 204 719 790 0 0
Totale 21.480